The Company treated the first patient in the pivotal Phase 3 OVATION 3 Study in July 2025 and is working with trial investigators to expand clinical sites and accelerate enrollment. Four sites have ...

Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single ...

Ferring Pharmaceuticals announced today that three abstracts featuring ADSTILADRIN® (nadofaragene firadenovec-vncg) will be presented at the 101st Annual Meeting of the Western Section of the American ...

REGENXBIO Inc. today announced the completion of enrollment in the AFFINITY DUCHENNE® pivotal trial of RGX-202, an investigational gene therapy for the treatment of Duchenne muscular dystrophy, as ...

Hanmi Pharmaceutical, the core business subsidiary of Hanmi Science, unveiled a range of next-generation modality research achievements at a ...

A rising wave of tumor-agnostic therapies were one of ESMO’s themes, highlighted during the opening press conference by Toni ...

Bengaluru (Karnataka) [India], October 28: Flix, a global travel tech leader and DKMS, an international non-profit organization dedicated to saving the lives of patients with blood cancer and blood ...

Success can be inherited, but the most inspiring stories are built from scratch. The Top 10 Self-Made Women in 2025 ...

The Royal Gorge Route Railroad in Cañon City isn’t just a train ride – it’s a moving time capsule that delivers you through some of the most spectacular scenery the Centennial State has to offer, all ...

The Royal Gorge Route Railroad in Cañon City isn’t just a train ride – it’s a moving time capsule that delivers you through some of the most spectacular scenery the Centennial State has to offer, all ...

A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...